Epidermal Growth Factor and Acute Radiation Damage in CDF1 Mice in Vivo

Authors

  • Jacob Chr. Lindegaard Dept. of Oncology, Aarhus University Hospital, Denmark
  • Lars Vinter-Jensen Dept. of Clinical Biochemistry, Aarhus University Hospital, Denmark
  • Jens Overgaard Danish Cancer Society, Dept. of Experimental Clinical Oncology, Denmark

DOI:

https://doi.org/10.3109/02841869709001286

Abstract

The aim was to investigate if extent and time course of acute radiation damage to epidermis and intestine could be moderated by epidermal growth factor (EGF). Twelve-to-sixteen weeks old female CDFl mice were treated either by single dose local irradiation to the right hind leg or total body irradiation (TBI). The endpoints were skin score and lethality, respectively. Human recombinant EGF was given s.c. or i.p. at a dose of 5–10 μg/day either before or after irradiation. Body weight was significantly higher for EGF treated animals compared with controls treated with saline. However, EGF did not reduce the median skin score following local irradiation and did not increase LD50 (days 1 -6) following TBI. Further studies using more specific assays are necessary to determine if radiation damage to less toxic levels can be ameliorated by EGF.

Downloads

Download data is not yet available.

Downloads

Published

1997-01-01

How to Cite

Lindegaard, J. C., Vinter-Jensen, L., & Overgaard, J. (1997). Epidermal Growth Factor and Acute Radiation Damage in CDF1 Mice in Vivo. Acta Oncologica, 36(4), 393–396. https://doi.org/10.3109/02841869709001286